Toward constructing an endophenotype strategy for bipolar disorders

被引:293
作者
Hasler, Gregor
Drevets, Wayne C.
Gould, Todd D.
Gottesman, Irving I.
Manji, Husseini K.
机构
[1] NIMH, Mood & Anxiety Disorders Program, Bethesda, MD 20892 USA
[2] Univ Minnesota, Sch Med, Dept Psychiat & Psychol, Minneapolis, MN USA
关键词
intermediate phenotype; biological marker; bipolar disorder; genetics; twins; families; endophenotypic;
D O I
10.1016/j.biopsych.2005.11.006
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Research aimed at elucidating the underlying neurobiology and genetics of bipolar disorder and factors associated with treatment response,. have been limited by a heterogeneous clinical phenotype and lack of knowledge about its underlying diathesis. We used a survey of clinical.. epidemiological, neurobiological, and genetic studies to select and evaluate candidate endophenotypes for bipolar disorder. Numerous findings regarding brain function, brain structure, and response to pharmacological challenge in bipolar patients and their relatives deserve further investigation. Candidate brain function endophenotypes include attention deficits, deficits in verbal learning and memory, cognitive deficits after tryptophan depletion. circadian rhythm instability, and dysmodulation of motivation and reward. We selected reduced anterior cingulate volume and early-onset white matter abnormalities as candidate brain structure endophenotypes. Symptom provocation endophenotypes might be based on bipolar patients' sensitivity to sleep deprivation. psychostimulants, and cholinergic drugs. Phenotypic heterogeneity is a major impediment to the elucidation of the neurobiology and genetics of bipolar disorder. We present a strategy constructed to improve the phenotypic definition of bipolar disorder by elucidating candidate endophenotypes. Studies to evaluate candidate endophenotypes with respect to specificity, heritability temporal stability, and prevalence in unaffected relatives are encouraged.
引用
收藏
页码:93 / 105
页数:13
相关论文
共 208 条
  • [1] Attentional vulnerability indicators in schizophrenia and bipolar disorder
    Addington, J
    Addington, D
    [J]. SCHIZOPHRENIA RESEARCH, 1997, 23 (03) : 197 - 204
  • [2] Familial leukoencephalopathy in bipolar disorder
    Ahearn, EP
    Steffens, DC
    Cassidy, F
    Van Meter, SA
    Provenzale, JM
    Seldin, MF
    Weisler, RH
    Krishnan, KRR
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 1998, 155 (11) : 1605 - 1607
  • [3] White matter hyperintensities in subjects with bipolar disorder
    Ahn, KH
    Lyoo, IK
    Lee, HK
    Song, IC
    Oh, JS
    Hwang, J
    Kwon, J
    Kim, MJ
    Kim, M
    Renshaw, PF
    [J]. PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2004, 58 (05) : 516 - 521
  • [4] The evolving bipolar spectrum - Prototypes I, II, III, and IV
    Akiskal, HS
    Pinto, O
    [J]. PSYCHIATRIC CLINICS OF NORTH AMERICA, 1999, 22 (03) : 517 - +
  • [5] Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects
    Altshuler, LL
    Ventura, J
    van Gorp, WG
    Green, MF
    Theberge, DC
    Mintz, J
    [J]. BIOLOGICAL PSYCHIATRY, 2004, 56 (08) : 560 - 569
  • [6] ALTSHULER LL, 1995, AM J PSYCHIAT, V152, P1139
  • [7] Effect of catecholamine depletion on lithium-induced long-term remission of bipolar disorder
    Anand, A
    Darnell, A
    Miller, HL
    Berman, RM
    Cappiello, A
    Oren, DA
    Woods, SW
    Charney, DS
    [J]. BIOLOGICAL PSYCHIATRY, 1999, 45 (08) : 972 - 978
  • [8] Brain SPECT imaging of amphetamine-induced dopamine release in euthymic bipolar disorder patients
    Anand, A
    Verhoeff, P
    Seneca, N
    Zoghbi, SS
    Seibyl, JP
    Charney, DS
    Innis, RB
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2000, 157 (07) : 1108 - 1114
  • [9] Angst J, 1968, Arch Psychiatr Nervenkr (1970), V210, P373, DOI 10.1007/BF00342013